Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs Sells 943 Shares

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 943 shares of Vicarious Surgical stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $14.53, for a total transaction of $13,701.79. Following the transaction, the chief executive officer now directly owns 52,699 shares in the company, valued at $765,716.47. The trade was a 1.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Adam David Sachs also recently made the following trade(s):

• On Monday, December 23rd, Adam David Sachs sold 139 shares of Vicarious Surgical stock. The stock was sold at an average price of $12.27, for a total transaction of $1,705.53.
• On Tuesday, December 3rd, Adam David Sachs sold 463 shares of Vicarious Surgical stock. The stock was sold at an average price of $13.50, for a total transaction of $6,250.50.

Vicarious Surgical Stock Performance

Shares of RBOT opened at $14.38 on Friday. Vicarious Surgical Inc has a twelve month low of $4.27 and a twelve month high of $19.00. The firm’s 50 day moving average price is $13.65 and its two-hundred day moving average price is $10.11. The firm has a market cap of $84.99 million, a P/E ratio of -1.40 and a beta of 1.32.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC lifted its stake in Vicarious Surgical by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after buying an additional 2,336 shares in the last quarter. DnB Asset Management AS lifted its stake in Vicarious Surgical by 21.1% in the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after buying an additional 3,692 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its stake in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after buying an additional 1,200 shares in the last quarter. Institutional investors own 47.27% of the company’s stock.

Analysts Set New Price Targets

Separately, Piper Sandler reduced their price objective on shares of Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a research note on Wednesday, November 13th.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.